CPC A61K 33/00 (2013.01) [A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/17 (2013.01); A61K 31/4418 (2013.01); A61K 31/4709 (2013.01); A61K 31/519 (2013.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 17/00 (2018.01); A61P 43/00 (2018.01); C01B 21/50 (2013.01); Y02A 50/30 (2018.01); Y10T 436/204998 (2015.01)] | 24 Claims |
1. A method for treating a dermatological disease or a condition associated with the skin, comprising administering to a subject having the dermatological disease or condition associated with the skin a therapeutically effective amount of sodium nitrite which contains no greater than about 0.02% by weight of sodium carbonate, contains no greater than about 10 ppm of an anti-caking agent, has a loss on drying of no greater than about 0.25% by weight, wherein the water content is no greater than about 0.5% by weight, wherein the heavy metal content is no greater than about 10 ppm, contains no greater than about 0.4% by weight of sodium nitrate, contains no greater than about 0.005% by weight of insoluble matter, contains no greater than about 0.005% by weight of chloride, contains no greater than about 0.01% by weight of sulfate, contains no greater than about 0.001% by weight of iron, contains no greater than about 0.01% by weight of calcium, contains no greater than about 0.005% by weight of potassium, contains no greater than about 0.05 ppm of mercury, contains no greater than about 2 ppm of aluminum, contains no greater than about 3 ppm of arsenic, contains no greater than about 0.003% by weight of selenium, contains no greater than about 5000 ppm of ethanol, contains no greater than about 3000 ppm methanol, wherein the total non-volatile organic carbon content is no greater than about 10 ppm, and contains no greater than about 0.25 EU/mg of bacterial endotoxins.
|